The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients.

Makiko So Taito Miyamoto Ryusuke Murakami Kaoru Abiko Junzo Hamanishi Tsukasa Baba Masaki Mandai

Published in: Journal of gynecologic oncology (2020)

SCS combined with chemotherapy results in better PFS and OS than chemotherapy alone in first platinum-sensitive ROC patients categorized as low-risk by Tian's model.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
squamous cell carcinoma
coronary artery disease
acute coronary syndrome
young adults
percutaneous coronary intervention
coronary artery bypass